|
Name |
Aspergillussanone H
|
Molecular Formula | C35H42O9 | |
IUPAC Name* |
2,4,6,9-tetrahydroxy-2-[10-[6-(2-hydroxypropan-2-yl)-2-oxooxan-3-ylidene]-3,7-dimethyldeca-2,6-dienyl]-5,7-dimethylphenalene-1,3-dione
|
|
SMILES |
CC(=CCCC(C)=CCC1(O)C(=O)c2c(O)cc(C)c3c(O)c(C)c(O)c(c23)C1=O)CCC=C1CCC(C(C)(C)O)OC1=O
|
|
InChI |
InChI=1S/C35H42O9/c1-18(11-8-12-22-13-14-24(34(5,6)42)44-33(22)41)9-7-10-19(2)15-16-35(43)31(39)26-23(36)17-20(3)25-27(26)28(32(35)40)30(38)21(4)29(25)37/h9,12,15,17,24,36-38,42-43H,7-8,10-11,13-14,16H2,1-6H3/b18-9+,19-15+,22-12-/t24?,35-/m0/s1
|
|
InChIKey |
YYWMWEQDOJVEPY-BGVHUSLVSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 606.71 | ALogp: | 5.9 |
HBD: | 5 | HBA: | 9 |
Rotatable Bonds: | 9 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 161.6 | Aromatic Rings: | 4 |
Heavy Atoms: | 44 | QED Weighted: | 0.1 |
Caco-2 Permeability: | -4.75 | MDCK Permeability: | 0.00001230 |
Pgp-inhibitor: | 0.061 | Pgp-substrate: | 0.004 |
Human Intestinal Absorption (HIA): | 0.323 | 20% Bioavailability (F20%): | 0.602 |
30% Bioavailability (F30%): | 0.075 |
Blood-Brain-Barrier Penetration (BBB): | 0.025 | Plasma Protein Binding (PPB): | 96.23% |
Volume Distribution (VD): | 0.967 | Fu: | 4.19% |
CYP1A2-inhibitor: | 0.148 | CYP1A2-substrate: | 0.157 |
CYP2C19-inhibitor: | 0.154 | CYP2C19-substrate: | 0.102 |
CYP2C9-inhibitor: | 0.713 | CYP2C9-substrate: | 0.883 |
CYP2D6-inhibitor: | 0.347 | CYP2D6-substrate: | 0.129 |
CYP3A4-inhibitor: | 0.339 | CYP3A4-substrate: | 0.36 |
Clearance (CL): | 1.196 | Half-life (T1/2): | 0.021 |
hERG Blockers: | 0.001 | Human Hepatotoxicity (H-HT): | 0.263 |
Drug-inuced Liver Injury (DILI): | 0.739 | AMES Toxicity: | 0.165 |
Rat Oral Acute Toxicity: | 0.025 | Maximum Recommended Daily Dose: | 0.254 |
Skin Sensitization: | 0.197 | Carcinogencity: | 0.818 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.009 |
Respiratory Toxicity: | 0.111 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005338 | 0.726 | D03VFL | 0.281 | ||||
ENC005339 | 0.715 | D0WY9N | 0.256 | ||||
ENC005337 | 0.700 | D0G4OD | 0.246 | ||||
ENC003495 | 0.671 | D0FX2Q | 0.243 | ||||
ENC003842 | 0.657 | D0G3DL | 0.226 | ||||
ENC003496 | 0.657 | D04FBR | 0.220 | ||||
ENC003114 | 0.655 | D09XWD | 0.220 | ||||
ENC003494 | 0.627 | D05XQE | 0.219 | ||||
ENC005341 | 0.596 | D0G9IU | 0.218 | ||||
ENC004068 | 0.340 | D08LTU | 0.213 |